Wockhardt Issues U.S. Recall Of Toprol ER Generic Hypertension Drug
This article was originally published in PharmAsia News
Executive Summary
Wockhardt issued a U.S. recall of 109,744 bottles of its generic version of AstraZeneca's Toprol (metropolol) drug for treating high blood pressure, a drug made at a plant not under U.S. FDA import alerts.